David Kleiner
David Kleiner
National Cancer Institute
Verified email at mail.nih.gov
Title
Cited by
Cited by
Year
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner, EM Brunt, M Van Natta, C Behling, MJ Contos, OW Cummings, ...
Hepatology 41 (6), 1313-1321, 2005
77352005
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis
AJ Sanyal, N Chalasani, KV Kowdley, A McCullough, AM Diehl, NM Bass, ...
New England Journal of Medicine 362 (18), 1675-1685, 2010
27382010
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
BA Neuschwander-Tetri, R Loomba, AJ Sanyal, JE Lavine, ML Van Natta, ...
The Lancet 385 (9972), 956-965, 2015
16822015
Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease
P Angulo, DE Kleiner, S Dam-Larsen, LA Adams, ES Bjornsson, ...
Gastroenterology 149 (2), 389-397. e10, 2015
16582015
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
K Promrat, DE Kleiner, HM Niemeier, E Jackvony, M Kearns, JR Wands, ...
Hepatology 51 (1), 121-129, 2010
12072010
Quantitative zymography: detection of picogram quantities of gelatinases
DE Kleiner, WG Stetlerstevenson
Analytical biochemistry 218 (2), 325-329, 1994
11591994
Matrix metalloproteinases and metastasis
DE Kleiner, WG Stetler-Stevenson
Cancer chemotherapy and pharmacology 43 (1), S42-S51, 1999
10151999
Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial
JE Lavine, JB Schwimmer, ML Van Natta, JP Molleston, KF Murray, ...
Jama 305 (16), 1659-1668, 2011
9832011
Comprehensive and integrative genomic characterization of hepatocellular carcinoma
A Ally, M Balasundaram, R Carlsen, E Chuah, A Clarke, N Dhalla, RA Holt, ...
Cell 169 (7), 1327-1341. e23, 2017
9342017
A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis
K Promrat, G Lutchman, GI Uwaifo, RJ Freedman, A Soza, T Heller, E Doo, ...
Hepatology 39 (1), 188-196, 2004
9272004
Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings
EM Brunt, DE Kleiner, LA Wilson, P Belt, BA Neuschwander‐Tetri, ...
Hepatology 53 (3), 810-820, 2011
9132011
Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte–associated antigen 4
KE Beck, JA Blansfield, KQ Tran, AL Feldman, MS Hughes, RE Royal, ...
Journal of clinical oncology: official journal of the American Society of …, 2006
8052006
Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome
P Ducrotté, P Sawant, V Jayanthi
World journal of gastroenterology: WJG 18 (30), 4012, 2012
803*2012
Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis
WG Stetler‐Stevenson, LA Liotta, DE Kleiner Jr
The FASEB Journal 7 (15), 1434-1441, 1993
7611993
Morson and Dawson's gastrointestinal pathology
DW Day, JR Jass, AB Price, NA Shepherd, JM Sloan, NJ Talbot, ...
John Wiley & Sons, 2008
759*2008
Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B
R McKenzie, MW Fried, R Sallie, H Conjeevaram, AM Di Bisceglie, Y Park, ...
New England Journal of Medicine 333 (17), 1099-1105, 1995
6421995
Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4
HS Kuehn, W Ouyang, B Lo, EK Deenick, JE Niemela, DT Avery, ...
Science 345 (6204), 1623-1627, 2014
6412014
Endpoints and clinical trial design for nonalcoholic steatohepatitis
AJ Sanyal, EM Brunt, DE Kleiner, KV Kowdley, N Chalasani, JE Lavine, ...
Hepatology 54 (1), 344-353, 2011
6192011
Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1
HS Conjeevaram, MW Fried, LJ Jeffers, NA Terrault, TE Wiley–Lucas, ...
Gastroenterology 131 (2), 470-477, 2006
5822006
Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte–associated antigen 4 blockade and interleukin 2: a phase I/II study
AV Maker, GQ Phan, P Attia, JC Yang, RM Sherry, SL Topalian, ...
Annals of surgical oncology 12 (12), 1005-1016, 2005
5462005
The system can't perform the operation now. Try again later.
Articles 1–20